wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26777506-1CEE6C24-341B-4430-9FEE-C53257BE5251
Q26777506-1CEE6C24-341B-4430-9FEE-C53257BE5251
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777506-1CEE6C24-341B-4430-9FEE-C53257BE5251
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
P2860
Q26777506-1CEE6C24-341B-4430-9FEE-C53257BE5251
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777506-1CEE6C24-341B-4430-9FEE-C53257BE5251
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eddbed96d59c981c7b522a584cc70faa468fb61b
P2860
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.